Progressive drug licensing: An opportunity to achieve transparency and accountability?
- Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts. Long, Richard; Houston, Stan; Hershfield, Earl // CMAJ: Canadian Medical Association Journal;10/14/2003, Vol. 169 Issue 8, p789
Presents the recommendations issued by the Canadian Tuberculosis Committee of the Center for Infectious Disease Prevention and Control of the Population and Health Branch of Health Canada in October 2003 for screening and prevention of tuberculosis (TB) in patients with HIV and for HIV in...
- Inadvertent injection of topical/nasal Adrenalin. // Reactions Weekly;8/28/2010, Issue 1316, p5
The article reports on the "Dear Health Care Professional" letter issued by Health Canada about the risk of inadvertent injection of a topical/nasal formulation of epinephrine chloride due to similarities in its packaging compared with other injectable-use vials.
- Health Canada set to shake Canadians' lust for salt. // Active Living;May2010, Vol. 19 Issue 3, p32
The article reports on the Sodium Reduction Strategy of Health Canada, an initiative which will be launched in July 2010 to reduce the daily intake of salt among Canadians.
- Health Canada targets postmarket surveillance of drugs. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;6/11/2002, Vol. 166 Issue 12, p1580
Focuses on the efforts of Health Canada to provide postmarket monitoring of products ranging from drugs and vaccines to foods that make health claims. Development of the Marketed Health Products Directorate.
- Health Canada's Progressive Licensing Framework. Yeates, Neil; Lee, David K.; Maher, Maurica // CMAJ: Canadian Medical Association Journal Supplement;6/19/2007, Vol. 176 Issue 13, p1845
The authors reflect on the progressive licensing framework of the Health Canada for pharmaceutical and biologic products. They provide an overview of the framework. They stress that the agency should enhance the post-market surveillance of drugs after the high-profile withdrawal of drugs from...
- Progressive drug licensing: An opportunity to achieve transparency and accountability? Wright, James M. // CMAJ: Canadian Medical Association Journal Supplement;6/19/2007, Vol. 176 Issue 13, p1848
The author reflects on the need for the Health Canada to overhaul its progressive licensing framework for pharmaceutical and biologic products. He stresses that the agency rarely initiate drug withdrawals or place warning label about the drugs' side effects that are initiated in other countries....
- Health Canada Fears Drugs in Water Supply. // Natural Life;Nov/Dec2001, Issue 82, p28
Reports on the concerns of Health Canada on the penetration of drugs in water supply. Announcement on the launching of research initiatives on minimization of risks; Plans to review products regulated by the Food and Drugs Act; Presence of drugs in the Canadian drinking water.
- Overweight, inactive kids worry Health Canada. Wharry, Steven // CMAJ: Canadian Medical Association Journal;5/28/2002, Vol. 166 Issue 11, p1450
Reports on plans of Health Canada to encourage increased physical activity among children by at least 30 minutes a day. Report for the World Health Organization regarding deaths from inactivity; How sedentary lifestyles contribute to illnesses, such as cardiovascular disease and diabetes;...
- Web Resources for Oral Health Professionals. // Journal of the Canadian Dental Association;Jun2001, Vol. 67 Issue 6, p310
The article reports that the web site of Health Canada's Bureau of Licensed Product Assessment now provides advisories on safety, public health and dental industry news.